Aug. 10, 2021 – The FDA is finalizing the burden estimates of complying with statutory requirements and guidance documents it previously issued on prescription drug advertising and the information drug companies communicate to payers and formulary committees and will accept comments on these estimates until Aug. 23. According a notice published in the July 23 […]
Read more
Jan. 22, 2018 – The House Energy and Commerce Subcommittee on Health held a markup Jan. 17 that advances H.R. 2026 (http://bit.ly/2G4cRM1), the “Pharmaceutical Information Exchange Act,” which will clarify how drug and medical device companies can share health care economic or scientific information about investigational drugs or devices with payers and formulary committees. “By […]
Read more